In prostate cancer cells, A3AR activation inhibited PKA-mediated ERK 1/2 activation and subsequent NADPH oxidase activities, resulting in decreased proliferation and invasion of cells [47]. The gene discussed is FMO5; the disease is Familial prostate cancer.